Sign in

CIK 0001674416 · Large accelerated filer

CRISPR Therapeutics AG

Sign in to watch
Ticker
CRSP
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
Switzerland
Entity type
operating
EIN
473173478
Phone
6173154600
Business address
BAARERSTRASSE 14, ZUG, Switzerland
Former names
CRISPR Therapeutics AG
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$4,881,673
in 7 filings, $1.5M under 10b5-1 plans

Net −$4,881,673. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Kulkarni Samarth −$2.6M Chief Executive Officer sold 14% of stake
  2. KASINGER JAMES R. −$797K General Counsel and Secretary sold 12% of stake
  3. Behbahani Ali −$781K Director sold 45% of stake
  4. George Simeon −$720K Director sold 48% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-10-14 Smith Brendan Chief Financial Officer Grant or award · Stock Option (Right to Buy) +90,000 90,000
2021-09-13 KASINGER JAMES R. General Counsel and Secretary Shares withheld for taxes −4,741 $117.86 $559K 29,170
2021-09-13 Klein Lawrence Otto CBO & COO Shares withheld for taxes −4,207 $117.86 $496K 6,843
2021-09-10 KASINGER JAMES R. General Counsel and Secretary Option exercise +10,000 33,911
2021-09-10 KASINGER JAMES R. General Counsel and Secretary Returned to the company · Restricted Stock Units −10,000 0
2021-09-10 Klein Lawrence Otto CBO & COO Option exercise +10,000 11,050
2021-09-10 Klein Lawrence Otto CBO & COO Shares withheld for taxes · Restricted Stock Units −10,000 0
2021-09-01 Kulkarni Samarth Chief Executive Officer Shares withheld for taxes −787 $124.83 $98K 186,932
2021-08-06 TOMSICEK MICHAEL JOHN Chief Financial Officer Option exercise +25,000 $17.75 $444K 26,891
2021-08-06 TOMSICEK MICHAEL JOHN Chief Financial Officer Sale −19,011 $138.22 $2.6M 7,880
2021-08-06 TOMSICEK MICHAEL JOHN Chief Financial Officer Sale −5,989 $139.46 $835K 1,891
2021-08-05 Kulkarni Samarth Chief Executive Officer Option exercise +28,500 $12.57 $358K 216,219
2021-08-05 Kulkarni Samarth Chief Executive Officer Sale −1,000 $126.67 $127K 215,219
2021-08-05 Kulkarni Samarth Chief Executive Officer Sale −4,700 $127.82 $601K 210,519
2021-08-05 Kulkarni Samarth Chief Executive Officer Sale −13,499 $128.85 $1.7M 197,020
2021-08-05 Kulkarni Samarth Chief Executive Officer Sale −6,819 $129.82 $885K 190,201
2021-08-05 Kulkarni Samarth Chief Executive Officer Sale −2,482 $130.51 $324K 187,719
2021-08-05 Kulkarni Samarth Chief Executive Officer Option exercise · Stock Option (Right to Buy) −28,500 33,333
2021-08-04 Kulkarni Samarth Chief Executive Officer Option exercise +1,500 $12.57 $19K 189,219
2021-08-04 Kulkarni Samarth Chief Executive Officer Sale −1,500 $125.02 $188K 187,719

Page 25 of 46 · 910 trades